IMVT - Immunovant  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

IMVT is currently covered by 10 analysts with an average price target of $43.55. This is a potential upside of $14.94 (5.99%) from yesterday's end of day stock price of $41.09.

Immunovant 's activity chart (see below) currently has 99 price targets and 110 ratings on display. The stock rating distribution of IMVT is 31.58% HOLD and 68.42% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 49.94% with an average time for these price targets to be met of 170.33 days.

Highest price target for IMVT is $62, Lowest price target is $28, average price target is $43.55.

Most recent stock forecast was given by SAMANTHA SEMENKOW from CITI on 30-Jun-2026. First documented stock forecast 07-Jan-2020.

Currently out of the existing stock ratings of IMVT, 6 are a HOLD (31.58%), 13 are a BUY (68.42%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 11-Aug-2023

$61

$22.21 (57.26%)

$58

10 days ago
(30-Jun-2026)

1/6 (16.67%)

$22.47 (58.32%)

46

Buy Since 23-May-2023

$62

$23.15 (59.59%)

$44

1 months 14 days ago
(26-May-2026)

3/10 (30%)

$28.17 (83.27%)

119

Hold Since 14-Oct-2025

$30

$-8.85 (-22.78%)

$22

1 months 18 days ago
(22-May-2026)

4/6 (66.67%)

$-4.15 (-12.15%)

431

Buy Since 23-May-2023

$43

$4.15 (10.68%)

$30

1 months 19 days ago
(21-May-2026)

3/4 (75%)

$8.87 (25.99%)

278

Buy Since 29-Jul-2020

$40

$1.15 (2.96%)

$35

1 months 19 days ago
(21-May-2026)

15/25 (60%)

$5.87 (17.20%)

271

Show more analysts

Please expand the browser size to see the chart

What is IMVT (Immunovant ) average time for price targets to be met?

On average it took 170.33 days on average for the stock forecasts to be realized with a an average price target met ratio 49.94

Which analyst has the current highest performing score on IMVT (Immunovant ) with a proven track record?

Which analyst has the most public recommendations on IMVT (Immunovant )?

has 0 price targets and 0 ratings on IMVT

Which analyst is the currently most bullish on IMVT (Immunovant )?

Robyn Karnauskas with highest potential upside - $23.5

Which analyst is the currently most reserved on IMVT (Immunovant )?

Dennis Ding with lowest potential downside - -$18.85

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?